1 Min Read
SABCS 2025 showcased several new strides in breast cancer research, which continues to be one of the most diagnosed malignancies globally, owing to the breadth of its subtypes: HR+, HER2+ and TNBC, all of which respond differently. In recent years, there have been several leaps in treatment options that have improved both outcomes and overall… The post Developments in breast cancer: What’s new from SABCS 2025 appeared first on Drug Discovery and Development.
Work & Theory on December 25, 2025
Uncategorized